.

Madan Jagasia, M.D., M.B.B.S., M.S.

Madan Jagasia, M.D., M.B.B.S., M.S.Associate Professor of Medicine
Chief, Section of Hematology-Stem Cell Transplant
Director, Outpatient Transplant Program

Dr. Jagasia is an integral part of the long-term transplant clinic with a singular focus on delivering efficient and effective care to the transplant patient. His primary research interest is graft-versus-host disease (GVHD), an immune complication of allogeneic stem cell transplantation.

As a clinical investigator, he is actively trying to identify non-HLA genetic factors that predict development of both acute and chronic GVHD. The development of biomarkers that predict for type of organs affected with GVHD along with response to therapy is an important aspect of his research. He is actively involved in clinical trials targeting various manifestations of chronic GVHD, and is the site principal investigator for the national chronic GVHD consortium.

Dr. Jagasia received his MBBS from King Edward Memorial College in Mumbai, India.  He received his fellowship training at Vanderbilt University in hematology-oncology.  He pursued his Masters of Science in Clinical Investigation at Vanderbilt from 2004-2006.

Dr. Jagasia has authored and co-authored more than 80 research articles in peer reviewed-journals such as Blood, Journal of Clinical Oncology, Bone Marrow Transplantation and Biology of Blood and Marrow Transplantation. He has served as a reviewer for many of these journals. He is a member of the GVHD and Leukemia working committees for the of International Blood and Marrow Transplant Center.

“The interface of the  electronic medical record with the Diagnostic Management Team approach makes Diagnostic Mentor seamless, and allows the busy clinician to have a wealth of information about patients at their fingertips. I use it not only to make clinical decisions, but as a visual aid to explain the disease process to the patient.”


This page was last updated July 30, 2013 and is maintained by